DNASTAR signs Lasergene Multi-Site License Agreement with CDC

DNASTAR, a leading bioinformatics software company, announced today the signing of a broad license agreement for the use of its Lasergene^® sequence analysis software with the Coordinating Center for Infectious Disease (CCID) division of the Centers for Disease Control (CDC) in Atlanta, GA .

Under the terms of the site license, Lasergene can be used on the Atlanta campus of CDC as well as their other campus sites in Fort Collins, CO, Anchorage, AK and San Juan, PR. Lasergene is a comprehensive sequence analysis software that provides users with tools for performing a wide range of assembly, visualization and analysis operations on data generated by the conventional Sanger sequencing method as well as Next Generation techniques. The desktop software allows users to analyze samples ranging from small plasmids up to large bacterial genomes.

Bob Steinhauser, DNASTAR’s Director of Marketing, “The CDC is one of the premier molecular biology research centers in the world. DNASTAR has been building its relationship with the CDC for many years. Expansion of the agreement to that of a multi-site licensing arrangement is something that we are very proud to have finalized. We are very pleased that CDC chose our software for their sequence assembly and analysis research needs. We continue to see business trends where organizations elect to standardize their research platforms to make data sharing among their scientists easier and to simplify training. Lasergene’s novel features make it an excellent platform choice to base their future genomic research needs.”

Lasergene is a comprehensive, easy to use suite of tools for molecular biologists and geneticists used primarily in the assembly and analysis of DNA and protein sequences. The software provides researchers with a broad range of analysis tools that can be used with traditional and Next-Generation sequence analysis projects. It has been sold in over 65 countries worldwide and the CCID division of CDC joins a growing list of public and private organizations that are utilizing the Lasergene sequence analysis software program.